Transition from Osmometer A to the OsmoTECH® XT A Customer Perspective
This interview highlights Boston BioProducts’ transition from a legacy osmometer (referred to as Osmometer A) to the Advanced Instruments OsmoTECH® XT. This conversation is between Ben Duckless, Field Application Scientist at Nova Biomedical, and Vinny Chan, Process Development Manager at Boston BioProducts.
About the Interviewee
Vinny Chan is the Process Development Manager at Boston BioProducts, where he serves as the subject matter expert for osmolality testing and the method owner across process development and manufacturing workflows. With approximately five years at the company, Vinny has played a central role in scaling operations within a cGMP environment.
His responsibilities span hands-on instrument operation, method development, troubleshooting, and cross-functional collaboration with manufacturing, quality control, and process excellence teams. Through this work, he has been directly involved in evaluating legacy analytical systems and driving the transition to more robust, compliant, and scalable solutions.
Vinny’s experience working with both the legacy osmometer (Osmometer A) and the OsmoTECH XT provides a practical and detailed perspective on the operational challenges and measurable benefits associated with this transition.
Read the full interview here.